{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:51:13Z","timestamp":1792000273380,"version":"4.4.0"},"reference-count":143,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"vor","delay-in-days":46,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jinf.2022.10.022","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T11:39:08Z","timestamp":1666265948000},"page":"611-622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Meningococcal disease in North America: Updates from the Global Meningococcal Initiative"],"prefix":"10.1016","volume":"85","author":[{"given":"Edwin J.","family":"Asturias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xilian","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Bettinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0691-6568","authenticated-orcid":false,"given":"Ray","family":"Borrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delia Nais","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique A.","family":"Caugant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grettel Chanto","family":"Chacon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0339-0134","authenticated-orcid":false,"given":"Ener Cagri","family":"Dinleyici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3167-0168","authenticated-orcid":false,"given":"Gabriela","family":"Echaniz-Aviles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Glennie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee H.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7145-899X","authenticated-orcid":false,"given":"Rebecca L.","family":"Howie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1585-8897","authenticated-orcid":false,"given":"Mark","family":"Itsko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Lucidarme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6005-0558","authenticated-orcid":false,"given":"Jose Eduardo Oliva","family":"Marin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henju","family":"Marjuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy A.","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustapha M.","family":"Mustapha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan L.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belkis","family":"Romeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Sadarangani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1149-5905","authenticated-orcid":false,"given":"Xavier","family":"S\u00e1ez-Llorens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco A.P.","family":"S\u00e1fadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0716-3174","authenticated-orcid":false,"given":"Muhamed-Kheir","family":"Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond S.W.","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Vazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"De Wals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2022.10.022_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-61779-346-2_1","article-title":"Neisseria meningitidis: biology, microbiology, and epidemiology","volume":"799","author":"Rouphael","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jinf.2022.10.022_bib0002","first-page":"75","article-title":"Molecular mechanisms involved in the interaction of Neisseria meningitidis with cells of the human blood\u2013cerebrospinal fluid barrier","author":"Schubert-Unkmeir","year":"2017","journal-title":"Pathog Dis"},{"issue":"4","key":"10.1016\/j.jinf.2022.10.022_bib0003","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jinf.2020.05.079","article-title":"The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination","volume":"81","author":"Parikh","year":"2020","journal-title":"J Infect"},{"issue":"3","key":"10.1016\/j.jinf.2022.10.022_bib0004","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/01.inf.0000202065.03366.0c","article-title":"Population-based analysis of meningococcal disease mortality in the United States: 1990-2002","volume":"25","author":"Sharip","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"2 suppl","key":"10.1016\/j.jinf.2022.10.022_bib0005","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jadohealth.2016.04.012","article-title":"The global evolution of meningococcal epidemiology following the introduction of meningococcal vaccines","volume":"59","author":"Pelton","year":"2016","journal-title":"J Adolesc Health"},{"issue":"3","key":"10.1016\/j.jinf.2022.10.022_bib0006","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jinf.2021.11.016","article-title":"Surveillance and control of meningococcal disease in the COVID-19 era: a global meningococcal initiative review","volume":"84","author":"Alderson","year":"2022","journal-title":"J Infect"},{"issue":"5","key":"10.1016\/j.jinf.2022.10.022_bib0007","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jinf.2020.07.025","article-title":"Meningococcal disease surveillance in the Asia-Pacific region (2020): the global meningococcal initiative","volume":"81","author":"Aye","year":"2020","journal-title":"J Infect"},{"issue":"6","key":"10.1016\/j.jinf.2022.10.022_bib0008","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jinf.2019.10.018","article-title":"Prevention and control of meningococcal disease: updates from the global meningococcal initiative in Eastern Europe","volume":"79","author":"Bai","year":"2019","journal-title":"J infect"},{"key":"10.1016\/j.jinf.2022.10.022_bib0009","unstructured":"World Health Organization. Meningitis fact sheet. Accessed May 24, 2022. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/meningitis."},{"key":"10.1016\/j.jinf.2022.10.022_bib0010","unstructured":"Centers for Disease Control and Prevention. Manual for the surveillance of vaccine-preventable diseases. Chapter 8 : meningococcal. Accessed May 24, 2022. https:\/\/www.cdc.gov\/vaccines\/pubs\/surv-manual\/chpt08-mening.html."},{"key":"10.1016\/j.jinf.2022.10.022_bib0011","unstructured":"Centers for Disease Control and Prevention. Enhanced meningococcal disease surveillance report, 2019. Accessed May 24, 2022. https:\/\/www.cdc.gov\/meningococcal\/downloads\/NCIRD-EMS-Report-2019.pdf."},{"key":"10.1016\/j.jinf.2022.10.022_bib0012","unstructured":"Public Health Agency of Canada. Invasive meningococcal disease: surveillance. Accessed May 24, 2022. https:\/\/www.canada.ca\/en\/public-health\/services\/immunization\/vaccine-preventable-diseases\/invasive-meningococcal-disease\/surveillance.html."},{"issue":"9","key":"10.1016\/j.jinf.2022.10.022_bib0013","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/cid\/ciu597","article-title":"The impact of the meningococcal serogroup C conjugate vaccine in Canada between 2002 and 2012","volume":"59","author":"Sadarangani","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.jinf.2022.10.022_bib0014","doi-asserted-by":"crossref","first-page":"e44102","DOI":"10.1371\/journal.pone.0044102","article-title":"Laboratory-based surveillance of Neisseria meningitidis isolates from disease cases in Latin American and Caribbean countries, SIREVA II 2006-2010","volume":"7","author":"Ibarz-Pav\u00f3n","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2022.10.022_bib0015","unstructured":"Gobierino De M\u00e9xico. SINAVE - national epidemiological surveillance system. Accessed May 24, 2022. https:\/\/www.gob.mx\/salud\/acciones-y-programas\/sistema-nacional-de-vigilancia-epidemiologica#:~:text=El%20Sistema%20Nacional%20de%20Vigilancia,%C3%BAtil%20para%20la%20salud%20p%C3%BAblica."},{"key":"10.1016\/j.jinf.2022.10.022_bib0016","unstructured":"GIVEBPVac (Grupo Interinstitucional para La Vigilancia de Enfermedades Bacterianas Prevenibles por Vacunaci\u00f3n) 2019. Accessed July 05, 2022. https:\/\/www.insp.mx\/lineas-de-investigacion\/medicamentos-en-salud-publica\/sireva.html."},{"issue":"4","key":"10.1016\/j.jinf.2022.10.022_bib0017","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1590\/S1020-49892008001000004","article-title":"Culture- and antigen-negative meningitis in Guatemalan children","volume":"24","author":"Dueger","year":"2008","journal-title":"Rev Panam Salud Publica"},{"key":"10.1016\/j.jinf.2022.10.022_bib0018","unstructured":"Data Obtained from Gobierno De La Rep\u00fablica Dominicana Salud P\u00fablica. Accessed May 24, 2022. https:\/\/msp.gob.do\/web\/."},{"issue":"1","key":"10.1016\/j.jinf.2022.10.022_bib0019","doi-asserted-by":"crossref","DOI":"10.1080\/16549716.2020.1795963","article-title":"A twin disaster: addressing the COVID-19 pandemic and a cerebrospinal meningitis outbreak simultaneously in a low-resource country","volume":"13","author":"Adjorlolo","year":"2020","journal-title":"Glob Health Action"},{"issue":"5","key":"10.1016\/j.jinf.2022.10.022_bib0020","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jama.1995.03520290042027","article-title":"The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992","volume":"273","author":"Whalen","year":"1995","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jinf.2022.10.022_bib0021","first-page":"17","article-title":"Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 1999, through 31 December, 2001","volume":"30","author":"Squires","year":"2004","journal-title":"Can Commun Dis Rep"},{"key":"10.1016\/j.jinf.2022.10.022_bib0022","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8901847","article-title":"Epidemiology and control of meningococcal disease in Canada: a long, complex, and unfinished story","author":"De Wals","year":"2019","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"4","key":"10.1016\/j.jinf.2022.10.022_bib0023","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/cid\/ciy548","article-title":"Epidemiology of meningococcal disease outbreaks in the United States, 2009\u20132013","volume":"68","author":"Mbaeyi","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2022.10.022_bib0024","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s40471-018-0170-z","article-title":"A review of global epidemiology and response to meningococcal disease outbreaks among men who have sex with men, 2001\u20132018","volume":"5","author":"Oliver","year":"2018","journal-title":"Curr Epidemiol Rep"},{"issue":"3","key":"10.1016\/j.jinf.2022.10.022_bib0025","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3201\/eid2503.181574","article-title":"University-based outbreaks of meningococcal disease caused by serogroup B, United States, 2013-2018","volume":"25","author":"Soeters","year":"2019","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2022.10.022_bib0026","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/cid\/ciy548","article-title":"Epidemiology of meningococcal disease outbreaks in the United States, 2009-2013","volume":"68","author":"Mbaeyi","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2022.10.022_bib0027","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/2051013614526592","article-title":"An outbreak of serogroup C (ST-11) meningococcal disease in Tijuana, Mexico","volume":"2","author":"Chacon-Cruz","year":"2014","journal-title":"Ther Adv Vaccines"},{"key":"10.1016\/j.jinf.2022.10.022_bib0028","unstructured":"Data Obtained from National Notifiable Diseases Surveillance System. Accessed May 24, 2022. https:\/\/www.cdc.gov\/nndss\/index.html."},{"key":"10.1016\/j.jinf.2022.10.022_bib0029","unstructured":"Data Obtained from National Reference Center for Bacteriology (NRCB), INCIENSA. Accessed May 24, 2022. https:\/\/www.inciensa.sa.cr\/."},{"key":"10.1016\/j.jinf.2022.10.022_bib0030","unstructured":"Data Obtained from Department of Epidemiology, Gobierno Nacional De Panam\u00e1 (2022). Accessed May 24, 2022. https:\/\/www.minsa.gob.pa\/."},{"key":"10.1016\/j.jinf.2022.10.022_bib0031","unstructured":"Data Obtained from Active Bacterial Core Surveillance. Accessed May 24, 2022. https:\/\/www.cdc.gov\/abcs\/index.html#:~:text=Active%20Bacterial%20Core%20surveillance%20(ABCs)%20is%20an%20active%20laboratory%2D,pathogens%20of%20public%20health%20importance."},{"key":"10.1016\/j.jinf.2022.10.022_bib0032","unstructured":"Data Obtained from EMDS 2016-2019 Surveillance Data. Accessed May 24, 2022. https:\/\/www.cdc.gov\/meningococcal\/surveillance\/index.html."},{"key":"10.1016\/j.jinf.2022.10.022_bib0033","unstructured":"Abstract presented as CSTE 2022 #."},{"key":"10.1016\/j.jinf.2022.10.022_bib0034","unstructured":"Data Obtained from Ministerio de Salud P\u00fablica y Asistencia Social. National Epidemiological Bulletin. 2001, No. 17. Accessed May 24, 2022. https:\/\/www.mspas.gob.gt\/."},{"key":"10.1016\/j.jinf.2022.10.022_bib0035","unstructured":"Direcci\u00f3n General de Epidemiolog\u00eda. Anuario De Morbilidad. Secretar\u00eda de Salud de M\u00e9xico, 2015. https:\/\/epidemiologia.salud.gob.mx\/anuario\/html\/incidencia_casos.html."},{"key":"10.1016\/j.jinf.2022.10.022_bib0036","article-title":"Pediatric meningitis due to Neisseria meningitidis, Streptococcus pneumoniae and Group B Streptococcus in Tijuana, Mexico: active\/prospective surveillance, 2005-2018","volume":"6","author":"Chacon-Cruz","year":"2019","journal-title":"Ther Adv Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2022.10.022_bib0037","doi-asserted-by":"crossref","first-page":"120","DOI":"10.21149\/10790","article-title":"Increased incidence of Neisseria meningitidis infections in Nuevo Le\u00f3n, Mexico. Aumento de la incidencia de infecciones por Neisseria meningitidis en Nuevo Le\u00f3n, M\u00e9xico","volume":"62","author":"Ram\u00edrez-Elizondo","year":"2020","journal-title":"Salud Publica Mex"},{"issue":"2","key":"10.1016\/j.jinf.2022.10.022_bib0038","doi-asserted-by":"crossref","first-page":"165","DOI":"10.21149\/11725","article-title":"Aumento en casos de meningitis meningoc\u00f3cica en los estados del sur de M\u00e9xico","volume":"63","author":"Sol\u00f3rzano-Santos","year":"2021","journal-title":"Salud Publica Mex"},{"key":"10.1016\/j.jinf.2022.10.022_bib0039","unstructured":"Centers for Disease Control and Prevention. Meningococcal disease surveillance. Accessed May 24, 2022. https:\/\/www.cdc.gov\/meningococcal\/surveillance\/index.html."},{"key":"10.1016\/j.jinf.2022.10.022_bib0040","unstructured":"Enhanced meningococcal disease surveillance report, 2019. Accessed July 06, 2022. https:\/\/www.cdc.gov\/meningococcal\/downloads\/NCIRD-EMS-Report-2019.pdf."},{"key":"10.1016\/j.jinf.2022.10.022_bib0041","unstructured":"CDC unpublished data: Manuscript in preparation."},{"key":"10.1016\/j.jinf.2022.10.022_bib0042","unstructured":"Canada National Surveillance Data, presented at the Global Meningococcal Initiative 10th Regional Meeting: Meningococcal Disease in North America, March 21-24, 2022."},{"key":"10.1016\/j.jinf.2022.10.022_bib0043","unstructured":"NML unpublished data."},{"key":"10.1016\/j.jinf.2022.10.022_bib0044","unstructured":"Data obtained from Gorgas Memorial Institute. Accessed May 24, 2022. http:\/\/www.gorgas.gob.pa\/."},{"issue":"7\u20138","key":"10.1016\/j.jinf.2022.10.022_bib0045","doi-asserted-by":"crossref","first-page":"144","DOI":"10.14745\/ccdr.v43i78a01","article-title":"Increase in Neisseria meningitidis serogroup W invasive disease in Canada: 2009-2016","volume":"43","author":"Tsang","year":"2017","journal-title":"Can Commun Dis Rep"},{"issue":"8","key":"10.1016\/j.jinf.2022.10.022_bib0046","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/cid\/cix993","article-title":"Current epidemiology and trends in meningococcal disease\u2014United States, 1996\u20132015","volume":"66","author":"MacNeil","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2022.10.022_bib0047","unstructured":"Enhanced meningococcal disease surveillance report, 2019. Accessed August 09, 2022. https:\/\/www.cdc.gov\/meningococcal\/downloads\/NCIRD-EMS-Report-2019.pdf."},{"key":"10.1016\/j.jinf.2022.10.022_bib0048","unstructured":"Enhanced meningococcal disease surveillance report, 2016. Accessed August 09, 2022. https:\/\/www.cdc.gov\/meningococcal\/downloads\/NCIRD-EMS-Report.pdf."},{"key":"10.1016\/j.jinf.2022.10.022_bib0049","unstructured":"Enhanced meningococcal disease surveillance report, 2015. Accessed August 09, 2022. https:\/\/www.cdc.gov\/meningococcal\/downloads\/NCIRD-EMS-Report-2015.pdf."},{"key":"10.1016\/j.jinf.2022.10.022_bib0050","unstructured":"Enhanced meningococcal disease surveillance report, 2017. Accessed August 09, 2022. https:\/\/www.cdc.gov\/meningococcal\/downloads\/NCIRD-EMS-Report-2017.pdf."},{"key":"10.1016\/j.jinf.2022.10.022_bib0051","unstructured":"Enhanced meningococcal disease surveillance report, 2018. Accessed August 09, 2022. https:\/\/www.cdc.gov\/meningococcal\/downloads\/NCIRD-EMS-Report-2018.pdf."},{"issue":"4","key":"10.1016\/j.jinf.2022.10.022_bib0052","first-page":"407","article-title":"Impact of a mass immunization campaign against serogroup C meningococcus in the Province of Quebec","volume":"74","author":"De Wals","year":"1996","journal-title":"Canada. Bull World Health Organ."},{"issue":"2","key":"10.1016\/j.jinf.2022.10.022_bib0053","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jama.285.2.177","article-title":"Effectiveness of a mass immunization campaign against serogroup C meningococcal disease in Quebec","volume":"285","author":"De Wals","year":"2001","journal-title":"JAMA"},{"issue":"20","key":"10.1016\/j.jinf.2022.10.022_bib0054","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1001\/jama.292.20.2491","article-title":"Effectiveness of a mass immunization campaign using serogroup C meningococcal conjugate vaccine","volume":"292","author":"De Wals","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jinf.2022.10.022_bib0055","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/cid\/cix154","article-title":"Impact of an immunization campaign to control an increased incidence of serogroup B meningococcal disease in one region of Quebec, Canada","volume":"64","author":"De Wals","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2022.10.022_bib0056","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1080\/21645515.2020.1804776","article-title":"Vaccines and routine immunization strategies during the COVID-19 pandemic","volume":"17","author":"Dinleyici","year":"2021","journal-title":"Hum Vaccin Immunother"},{"issue":"9","key":"10.1016\/j.jinf.2022.10.022_bib0057","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6909a1","article-title":"Meningococcal vaccination: recommendations of the advisory committee on immunization practices, United States, 2020","volume":"69","author":"Mbaeyi","year":"2020","journal-title":"MMWR Recomm Rep."},{"key":"10.1016\/j.jinf.2022.10.022_bib0058","unstructured":"Meningococcal vaccine: Canadian immunization guide (https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/canadian-immunization-guide-part-4-active-vaccines\/page-13-meningococcal-vaccine.html)."},{"key":"10.1016\/j.jinf.2022.10.022_bib0059","unstructured":"Government of Canada. Recommended immunization schedules: Canadian immunization guide. Accessed July, 05 2022. https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/canadian-immunization-guide-part-1-key-immunization-information\/page-13-recommended-immunization-schedules.html#p1c12a2."},{"key":"10.1016\/j.jinf.2022.10.022_bib0060","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.15585\/mmwr.mm7035a1","article-title":"National, regional, state, and selected local area vaccination coverage among adolescents aged 13\u201317 years \u2014 United States","volume":"70","author":"Pingali","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3\u20134","key":"10.1016\/j.jinf.2022.10.022_bib0061","first-page":"9","article-title":"Cuba's national regulatory authority & COVID-19: Olga Lidia Jacobo-Casanueva MS Director, Center for State Control of Drugs and Medical Devices (CECMED)","volume":"23","author":"Aguilar-Guerra","year":"2021","journal-title":"MEDICC Rev"},{"issue":"5","key":"10.1016\/j.jinf.2022.10.022_bib0062","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s43441-021-00300-0","article-title":"The role of regulatory sciences from the perspective of the Cuban medicines regulatory agency: the impact of COVID-19 in promoting innovation, cooperation and scientific thinking","volume":"55","author":"Romeu","year":"2021","journal-title":"Ther Innov Regul Sci"},{"key":"10.1016\/j.jinf.2022.10.022_bib0063","unstructured":"World Health Organisation. Immunization data. Accessed May 24, 2022. https:\/\/immunizationdata.who.int\/listing.html?topic=&location=."},{"key":"10.1016\/j.jinf.2022.10.022_bib0064","unstructured":"Data obtained from hospital del Ni\u00f1o. Accessed May 24, 2022. https:\/\/hn.sld.pa\/."},{"key":"10.1016\/j.jinf.2022.10.022_bib0065","unstructured":"World Health Organization. Launch of the defeating meningitis roadmap. Accessed May 24, 2022. https:\/\/www.who.int\/news-room\/events\/detail\/2021\/09\/28\/default-calendar\/launch-of-the-defeating-meningitis-roadmap."},{"key":"10.1016\/j.jinf.2022.10.022_bib0066","unstructured":"World Health Organization. Defeating meningitis by 2030. Accessed May 24, 2022. https:\/\/www.who.int\/initiatives\/defeating-meningitis-by-2030."},{"issue":"2 Suppl","key":"10.1016\/j.jinf.2022.10.022_bib0067","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.jadohealth.2016.04.013","article-title":"Treatment of meningococcal disease","volume":"59","author":"Nadel","year":"2016","journal-title":"J Adolesc Health"},{"issue":"Suppl1","key":"10.1016\/j.jinf.2022.10.022_bib0068","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1093\/clinids\/24.Supplement_1.S98","article-title":"Antibiotic resistance in Neisseria meningitidis","volume":"24","author":"Oppenheim","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.jinf.2022.10.022_bib0069","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260677","article-title":"Antibiotic resistance among invasive Neisseria meningitidis isolates in England, Wales and Northern Ireland (2010\/11 to 2018\/19)","volume":"16","author":"Willerton","year":"2021","journal-title":"PLoS One"},{"issue":"21","key":"10.1016\/j.jinf.2022.10.022_bib0070","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1016\/j.vaccine.2019.04.020","article-title":"Case fatality rates of invasive meningococcal disease by serogroup and age: a systematic review and meta-analysis","volume":"37","author":"Wang","year":"2019","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.jinf.2022.10.022_bib0071","doi-asserted-by":"crossref","first-page":"ofv117","DOI":"10.1093\/ofid\/ofv117","article-title":"Population-based surveillance of Neisseria meningitidis antimicrobial resistance in the United States","volume":"2","author":"Harcout","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jinf.2022.10.022_bib0072","first-page":"jiac046","article-title":"Antimicrobial susceptibility survey of invasive Neisseria meningitidis, United States 2012-2016","author":"Potts","year":"2022","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.jinf.2022.10.022_bib0073","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/cid\/ciab358","article-title":"Acquisition of ciprofloxacin resistance among an expanding clade of \u03b2-lactamase\u2013positive, serogroup Y Neisseria meningitidis in the United States","volume":"73","author":"Potts","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2022.10.022_bib0074","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/jpids\/piaa085","article-title":"\u03b2-Lactamase\u2013producing, ciprofloxacin-resistant Neisseria meningitidis isolated from a 5-month-old boy in the United States","volume":"10","author":"Taormina","year":"2021","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.jinf.2022.10.022_bib0075","unstructured":"Data obtained from bacterial meningitis laboratory (Centers for Disease Control and Prevention)."},{"key":"10.1016\/j.jinf.2022.10.022_bib0076","unstructured":"Bacterial meningitis genome analysis platform. Accessed May 24, 2022. https:\/\/github.com\/CDCgov\/BMGAP."},{"issue":"5","key":"10.1016\/j.jinf.2022.10.022_bib0077","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/jac\/dkab010","article-title":"Emergence of MDR invasive Neisseria meningitidis in El Salvador, 2017-19","volume":"76","author":"Mar\u00edn","year":"2021","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.jinf.2022.10.022_bib0078","first-page":"22","article-title":"WGS analysis of a penicillin-resistant Neisseria meningitidis strain containing a chromosomal ROB-1 \u03b2-lactamase gene","volume":"74","author":"Tsang","year":"2019","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"10.1016\/j.jinf.2022.10.022_bib0079","doi-asserted-by":"crossref","first-page":"e00818","DOI":"10.1128\/AAC.00831-18","article-title":"Acquisition of beta-lactamase by Neisseria meningitidis through possible horizontal gene transfer","volume":"62","author":"Hong","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2022.10.022_bib0080","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/cid\/ciab358","article-title":"Acquisition of ciprofloxacin resistance among an expanding clade of \u03b2-lactamase-positive, serogroup Y Neisseria meningitidis in the United States","volume":"73","author":"Potts","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2022.10.022_bib0081","unstructured":"INCIENSA (Instituto Costarricense de Investigaci\u00f3n y Ense\u00f1anza en Nutrici\u00f3n y Salud). Aislamientos De Neisseria meningitis Serogrupo Y resistentes a Penicilina y No Sensibles a Cefotaxime En Costa Rica. Accessed May 24, 2022. https:\/\/www.inciensa.sa.cr\/vigilancia_epidemiologica\/informes_vigilancia\/2020\/CNRB\/Alerta%20\u00a0N.%20meningitidis%20Y%20resistente%20a%20PEN%20no%20sensible%20a%20CTX%202020.pdf."},{"key":"10.1016\/j.jinf.2022.10.022_bib0082","unstructured":"BC Centre for Disease Control. Immunization coverage reports. Accessed May 24, 2022. http:\/\/www.bccdc.ca\/health-professionals\/data-reports\/immunizations."},{"key":"10.1016\/j.jinf.2022.10.022_bib0083","unstructured":"Public Health Agency of Canada. Highlights from the 2019 Childhood National Immunization Coverage Survey (cNICS). Accessed May 24, 2022. https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/vaccines-immunization\/2019-highlights-childhood-national-immunization-coverage-survey.html."},{"key":"10.1016\/j.jinf.2022.10.022_bib0084","unstructured":"BC Centre for Disease Control. Childhood immunization coverage dashboard. Accessed May 24, 2022. http:\/\/www.bccdc.ca\/health-professionals\/data-reports\/immunizations."},{"key":"10.1016\/j.jinf.2022.10.022_bib0085","unstructured":"Report of the SAGE working group on vaccine hesitancy. Accessed May 24, 2022. https:\/\/www.asset-scienceinsociety.eu\/sites\/default\/files\/sage_working_group_revised_report_vaccine_hesitancy.pdf."},{"issue":"4","key":"10.1016\/j.jinf.2022.10.022_bib0086","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.vaccine.2017.12.005","article-title":"Measuring vaccine acceptance among Canadian parents: a survey of the Canadian Immunization Research Network","volume":"36","author":"Dub\u00e9","year":"2018","journal-title":"Vaccine"},{"issue":"41","key":"10.1016\/j.jinf.2022.10.022_bib0087","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1016\/j.vaccine.2014.07.076","article-title":"Experiences with provider and parental attitudes and practices regarding the administration of multiple injections during infant vaccination visits: lessons for vaccine introduction","volume":"32","author":"Wallace","year":"2014","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.jinf.2022.10.022_bib0088","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1080\/21645515.2018.1451287","article-title":"Vaccination strategies for the prevention of meningococcal disease","volume":"14","author":"Vuocolo","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jinf.2022.10.022_bib0089","unstructured":"Schanzenbach D., Pitts A. (2020). Estimates of food insecurity during the covid-19 crisis: results from the COVID impact survey, Week 1 (April 20\u201326, 2020). 2020; 1:1\u201312."},{"issue":"3","key":"10.1016\/j.jinf.2022.10.022_bib0090","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jamaophthalmol.2020.6239","article-title":"Progression of myopia in school-aged children after COVID-19 home confinement","volume":"139","author":"Wang","year":"2021","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"10.1016\/j.jinf.2022.10.022_bib0091","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.ophtha.2021.04.001","article-title":"COVID-19 quarantine reveals that behavioral changes have an effect on myopia progression","volume":"128","author":"Xu","year":"2021","journal-title":"Opthalmology"},{"key":"10.1016\/j.jinf.2022.10.022_bib0092","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijsu.2020.04.018","article-title":"The socio-economic implications of the coronavirus pandemic (COVID-19): a review","volume":"78","author":"Nicola","year":"2020","journal-title":"Int J Surg"},{"issue":"4","key":"10.1016\/j.jinf.2022.10.022_bib0093","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S2352-4642(22)00005-0","article-title":"Global, regional, and national minimum estimates of children affected by COVID-19-associated orphanhood and caregiver death, by age and family circumstance up to Oct 31, 2021: an updated modelling study","volume":"6","author":"Unwin","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"issue":"10299","key":"10.1016\/j.jinf.2022.10.022_bib0094","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0140-6736(21)01337-4","article-title":"Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study","volume":"398","author":"Causey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2022.10.022_bib0095","article-title":"Impact of COVID-19 on routine immunisation in South-East Asia and Western Pacific: disruptions and solutions","volume":"10","author":"Harris","year":"2021","journal-title":"Lancet Reg Health West Pac"},{"issue":"5","key":"10.1016\/j.jinf.2022.10.022_bib0096","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.idnow.2021.05.004","article-title":"Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap?","volume":"51","author":"Cohen","year":"2021","journal-title":"Infect Dis Now"},{"issue":"19","key":"10.1016\/j.jinf.2022.10.022_bib0097","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.19.2000848","article-title":"Early impact of the coronavirus disease (COVID-19) pandemic and physical distancing measures on routine childhood vaccinations in England, January to April 2020","volume":"25","author":"McDonald","year":"2020","journal-title":"Euro Surveill"},{"issue":"1","key":"10.1016\/j.jinf.2022.10.022_bib0098","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1179\/2047773214Y.0000000126","article-title":"Global practices of meningococcal vaccine use and impact on invasive disease","volume":"108","author":"Ali","year":"2014","journal-title":"Pathog Glob Health"},{"issue":"9","key":"10.1016\/j.jinf.2022.10.022_bib0099","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1586\/erv.11.103","article-title":"Neisseria meningitidis B vaccines","volume":"10","author":"Panatto","year":"2011","journal-title":"Expert Rev Vaccines"},{"issue":"02","key":"10.1016\/j.jinf.2022.10.022_bib0100","first-page":"B87","article-title":"The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens","volume":"30","author":"Davide","year":"2013","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.jinf.2022.10.022_bib0101","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176177","article-title":"Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Portugal","volume":"12","author":"Sim\u00f5es","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jinf.2022.10.022_bib0102","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jinf.2020.07.034","article-title":"Methods to evaluate serogroup B meningococcal vaccines: from predictions to real-world evidence","volume":"81","author":"Borrow","year":"2020","journal-title":"J Infect"},{"issue":"45","key":"10.1016\/j.jinf.2022.10.022_bib0103","doi-asserted-by":"crossref","first-page":"19490","DOI":"10.1073\/pnas.1013758107","article-title":"Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines","volume":"107","author":"Donnelly","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.jinf.2022.10.022_bib0104","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1473-3099(13)70006-9","article-title":"Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment","volume":"13","author":"Vogel","year":"2013","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.jinf.2022.10.022_bib0105","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.vaccine.2018.12.061","article-title":"Genetic Meningococcal Antigen Typing System (gMATS): a genotyping tool that predicts 4CMenB strain coverage worldwide","volume":"37","author":"Muzzi","year":"2019","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jinf.2022.10.022_bib0106","first-page":"e02120","article-title":"Meningococcal Deduced Vaccine Antigen Reactivity (MenDeVAR) Index: a rapid and accessible tool that exploits genomic data in public health and clinical microbiology applications","volume":"59","author":"Rodrigues","year":"2021","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2022.10.022_bib0107","doi-asserted-by":"crossref","first-page":"e00018","DOI":"10.1128\/mBio.00036-18","article-title":"Predicting the susceptibility of meningococcal serogroup B isolates to bactericidal antibodies elicited by bivalent rLP2086, a novel prophylactic vaccine","volume":"9","author":"McNeil","year":"2018","journal-title":"MBio"},{"issue":"7","key":"10.1016\/j.jinf.2022.10.022_bib0108","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.vaccine.2018.12.061","article-title":"Genetic Meningococcal Antigen Typing System (gMATS): a genotyping tool that predicts 4CMenB strain coverage worldwide","volume":"37","author":"Muzzi","year":"2019","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.jinf.2022.10.022_bib0109","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/INF.0b013e31827b0d24","article-title":"A randomized, controlled, phase 1\/2 trial of a Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in healthy children and adolescents","volume":"32","author":"Nissen","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"43","key":"10.1016\/j.jinf.2022.10.022_bib0110","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1016\/j.vaccine.2012.07.065","article-title":"A bivalent Neisseria meningitidis recombinant lipidated factor H binding protein vaccine in young adults: results of a randomised, controlled, dose-escalation phase 1 trial","volume":"30","author":"Richmond","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jinf.2022.10.022_bib0111","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.vaccine.2013.03.063","article-title":"Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB)","volume":"32","author":"Bettinger","year":"2013","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.jinf.2022.10.022_bib0112","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/j.vaccine.2019.12.051","article-title":"Estimated susceptibility of Canadian meningococcal B isolates to a meningococcal serogroup B vaccine (MenB-FHbp)","volume":"38","author":"Betting","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2022.10.022_bib0113","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1073\/pnas.95.6.3140","article-title":"Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms","volume":"95","author":"Maiden","year":"1998","journal-title":"Proc Natl Acad USA"},{"key":"10.1016\/j.jinf.2022.10.022_bib0114","doi-asserted-by":"crossref","first-page":"15803","DOI":"10.1038\/s41598-018-33622-5","article-title":"Whole genome sequencing for investigations of meningococcal outbreaks in the United States: a retrospective analysis","volume":"8","author":"Whaley","year":"2018","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.jinf.2022.10.022_bib0115","doi-asserted-by":"crossref","first-page":"e01720","DOI":"10.1128\/JCM.01780-20","article-title":"Full molecular typing of Neisseria meningitidis directly from clinical specimens for outbreak investigation","volume":"58","author":"Itsko","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2022.10.022_bib0116","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiac104","article-title":"Enhancing meningococcal genomic surveillance in the meningitis belt using high-resolution culture-free whole genome sequencing","author":"Itsko","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2022.10.022_bib0117","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ebiom.2019.02.054","article-title":"Phylogenetic relationships and regional spread of meningococcal strains in the meningitis belt, 2011\u20132016","volume":"41","author":"Topaz","year":"2019","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.jinf.2022.10.022_bib0118","doi-asserted-by":"crossref","first-page":"13742","DOI":"10.1038\/s41598-019-50203-2","article-title":"Genomic characterization of novel Neisseria species","volume":"9","author":"Diallo","year":"2019","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.jinf.2022.10.022_bib0119","doi-asserted-by":"crossref","first-page":"e11835","DOI":"10.1371\/journal.pone.0011835","article-title":"Genome sequencing reveals widespread virulence gene exchange among human Neisseria species","volume":"5","author":"Marri","year":"2010","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.jinf.2022.10.022_bib0120","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/gbe\/evt116","article-title":"Homologous recombination drives both sequence diversity and gene content variation in Neisseria meningitidis","volume":"5","author":"Kong","year":"2013","journal-title":"Genome Biol Evol"},{"issue":"1","key":"10.1016\/j.jinf.2022.10.022_bib0121","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1073\/pnas.94.1.271","article-title":"Capsule switching of Neisseria meningitidis","volume":"94","author":"Swartley","year":"1997","journal-title":"Proc Natl Acad Sci U S A,"},{"issue":"2","key":"10.1016\/j.jinf.2022.10.022_bib0122","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3201\/eid2602.190191","article-title":"Two cases of newly characterized Neisseria species","volume":"26","author":"Mustapha","year":"2020","journal-title":"Brazil. Emerg Infect Dis."},{"issue":"1","key":"10.1016\/j.jinf.2022.10.022_bib0123","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12864-020-6511-6","article-title":"Genomic evolution of Neisseria gonorrhoeae since the preantibiotic era (1928-2013): antimicrobial use\/misuse selects for resistance and drives evolution","volume":"21","author":"Golparian","year":"2020","journal-title":"BMC Genomics"},{"issue":"5","key":"10.1016\/j.jinf.2022.10.022_bib0124","doi-asserted-by":"crossref","first-page":"e01619","DOI":"10.1128\/mBio.01668-19","article-title":"Genetic similarity of gonococcal homologs to meningococcal outer membrane proteins of serogroup B vaccine","volume":"10","author":"Marjuki","year":"2019","journal-title":"MBio"},{"issue":"2","key":"10.1016\/j.jinf.2022.10.022_bib0125","doi-asserted-by":"crossref","first-page":"110","DOI":"10.7774\/cevr.2019.8.2.110","article-title":"A meningococcal B vaccine induces cross-protection against gonorrhea","volume":"8","author":"Ochoa Azze","year":"2019","journal-title":"Clin Exp Vaccine Res"},{"issue":"7","key":"10.1016\/j.jinf.2022.10.022_bib0126","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1586\/erv.09.48","article-title":"Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs","volume":"8","author":"Trotter","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"9320","key":"10.1016\/j.jinf.2022.10.022_bib0127","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(02)08679-8","article-title":"Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination","volume":"359","author":"Maiden","year":"2002","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.jinf.2022.10.022_bib0128","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/cid\/ciu597","article-title":"The impact of the meningococcal serogroup C conjugate vaccine in Canada between 2002 and 2012","volume":"59","author":"Sadarangani","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2022.10.022_bib0129","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3390\/vaccines10040617","article-title":"Efficacy and effectiveness of the meningococcal conjugate group A vaccine MenAfriVac\u00ae in preventing recurrent meningitis epidemics in Sub-Saharan Africa","volume":"10","author":"Viviani","year":"2022","journal-title":"Vaccines"},{"issue":"10","key":"10.1016\/j.jinf.2022.10.022_bib0130","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1473-3099(12)70168-8","article-title":"Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data","volume":"12","author":"Novak","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2022.10.022_bib0131","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/cid\/cis892","article-title":"Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity","volume":"56","author":"Kristiansen","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2022.10.022_bib0132","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/S1473-3099(20)30239-5","article-title":"Meningococcal carriage 7 years after introduction of a serogroup A meningococcal conjugate vaccine in Burkina Faso: results from four cross-sectional carriage surveys","volume":"20","author":"Mbaeyi","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2022.10.022_bib0133","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1093\/cid\/ciaa1733","article-title":"Effectiveness of meningococcal vaccines at reducing invasive meningococcal disease and pharyngeal Neisseria meningitidis carriage: a systematic review and meta-analysis","volume":"73","author":"McMillan","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2022.10.022_bib0134","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2022.07.004","article-title":"Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme","author":"Carr","year":"2022","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"10.1016\/j.jinf.2022.10.022_bib0135","doi-asserted-by":"crossref","first-page":"e1661","DOI":"10.1093\/cid\/ciaa1244","article-title":"First real-world evidence of meningococcal group B vaccine, 4CMenB, protection against meningococcal group W disease: prospective enhanced national surveillance, England","volume":"73","author":"Ladhani","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2022.10.022_bib0136","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S2352-4642(21)00335-7","article-title":"Impact of an adolescent meningococcal ACWY immunisation programme to control a national outbreak of group W meningococcal disease in England: a national surveillance and modelling study","volume":"6","author":"Campbell","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"issue":"4","key":"10.1016\/j.jinf.2022.10.022_bib0137","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMoa1900236","article-title":"Meningococcal B vaccine and meningococcal carriage in adolescents in Australia","volume":"382","author":"Marshall","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2022.10.022_bib0138","doi-asserted-by":"crossref","unstructured":"Ramsay M.E., et\u00a0al. (2003). Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis;326:365\u20136","DOI":"10.1136\/bmj.326.7385.365"},{"key":"10.1016\/j.jinf.2022.10.022_bib0139","doi-asserted-by":"crossref","unstructured":"Campbell H., et\u00a0al. (2022). Impact of adolescent meningococcal ACWY immunisation programme to control a national outbreak of group W meningococcal disease in England: a national surveillance and modelling study;6:96\u2013105","DOI":"10.1016\/S2352-4642(21)00335-7"},{"key":"10.1016\/j.jinf.2022.10.022_bib0140","doi-asserted-by":"crossref","unstructured":"McMillan M., et\u00a0al. (2021). effectiveness of meningococcal vaccines at reducing invasive meningococcal disease and pharyngeal Neisseria meningitidis carriage: a systematic review and meta-analysis;73:e609\u201319","DOI":"10.1093\/cid\/ciaa1733"},{"key":"10.1016\/j.jinf.2022.10.022_bib0141","unstructured":"Public Health Agency of Canada. Invasive meningococcal disease. Accessed May 24, 2022. https:\/\/www.canada.ca\/en\/public-health\/services\/immunization\/vaccine-preventable-diseases\/invasive-meningococcal-disease\/health-professionals.html#figure1."},{"key":"10.1016\/j.jinf.2022.10.022_bib0142","unstructured":"Nationally Notifiable Infectious Diseases and Conditions (Centers for Disease Control and Prevention). Weekly cases of notifiable diseases, United States, U.S. territories, and non-U.S. Residents week ending January 2, 2021 (Week 53). Accessed May 24, 2022. https:\/\/wonder.cdc.gov\/nndss\/static\/2020\/53\/2020-53-table1w.html."},{"issue":"3","key":"10.1016\/j.jinf.2022.10.022_bib0143","first-page":"8","article-title":"Invasive meningococcal disease. Cuba, 1983-2006","volume":"19","author":"P\u00e9rez","year":"2010","journal-title":"Vaccimonitor"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445322006235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445322006235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:36:08Z","timestamp":1759008968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445322006235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":143,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0163445322006235"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2022.10.022","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meningococcal disease in North America: Updates from the Global Meningococcal Initiative","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2022.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}]}}